Studies from University of Oklahoma Have Provided New Data on Sepsis (Probiotic-Associated Central Venous Catheter Bloodstream Infections Lead to Increased Mortality in the ICU).

A recent report from the University of Oklahoma discusses research findings on sepsis and its association with probiotic-associated central venous catheter bloodstream infections in the ICU. The study found that among the patients who received probiotics, 0.37% experienced probiotic-associated infections, resulting in increased mortality. Powder formulations of probiotics were found to have a higher rate of infection compared to nonpowder formulations. The researchers concluded that the risks of probiotic-associated infections and death outweigh any potential benefits of probiotic administration in ICU patients with central venous catheters. [Extracted from the article]